A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
for Triple Negative Breast Cancer
3 locations incl. Columbus
Sponsor: Jina Pharmaceuticals Inc.
Sex: Female·Age: 18 - 65
Code: NCT03671044·Phase 3·Recruiting